Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yunlong Tan

Showing results (181-190 of 214) with videos related to

Pageof 22
Sort By:
Journal of Psychiatric Research|February 21, 2024
Correlation of allostatic load and perceived stress with clinical features in first-episode schizophreniaYanfang Zhou, Leilei Wang, Kebing Yang, et al.
Neuroscience Letters|August 9, 2022
Serum hyperhomocysteine and cognitive impairment in first-episode patients with schizophrenia: Moderated by brain cortical thicknessChen Lin, Mengzhuang Gou, Shujuan Pan, et al.
Psychiatric Genetics|September 14, 2023
A novel risk variant block across introns 36-45 of CACNA1C for schizophrenia: a cohort-wise replication and cerebral region-wide validation studyXiaoyun Guo, Shibin Wang, Xiandong Lin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 26, 2023
Role of the immune-kynurenine pathway in treatment-resistant schizophreniaWenjin Chen, Yichang Tian, Mengzhuang Gou, et al.
Psychiatry Research. Neuroimaging|February 17, 2020
Hippocampus and cognitive domain deficits in treatment-resistant schizophrenia: A comparison with matched treatment-responsive patients and healthy controls<sup>✰,✰✰,★,★★</sup>Junchao Huang, Yu Zhu, Fengmei Fan, et al.
Psychopharmacology|January 6, 2022
Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority studyLe Xiao, Qian Zhao, An-Ning Li, et al.
Molecular Neurobiology|November 6, 2023
Correlation of Immune-Inflammatory Response System (IRS)/Compensatory Immune-Regulatory Reflex System (CIRS) with White Matter Integrity in First-Episode Patients with SchizophreniaMengzhuang Gou, Wei Li, Jinghui Tong, et al.
Brain, Behavior, and Immunity|June 27, 2025
Serum kynurenine metabolites and cytokine levels: diagnostic and predictive implications in acute manic episodes of bipolar disorderWei Li, Zhaofan Liu, Jue Wang, et al.
Schizophrenia Bulletin|June 12, 2023
Pleiotropic Association of CACNA1C Variants With Neuropsychiatric DisordersZuxing Wang, Xiandong Lin, Xinqun Luo, et al.
Schizophrenia Bulletin|October 15, 2024
N-Methyl-d-Aspartate Receptor Antibody and Sensory Gating Deficits in Non-smoking, Minimal Antipsychotic Medication Exposure, and First-Episode Patients With SchizophreniaJinghui Tong, Kebing Yang, Wei Li, et al.
Pageof 22

Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
Journal of Psychiatric Research|February 21, 2024
Correlation of allostatic load and perceived stress with clinical features in first-episode schizophreniaYanfang Zhou, Leilei Wang, Kebing Yang, et al.
Neuroscience Letters|August 9, 2022
Serum hyperhomocysteine and cognitive impairment in first-episode patients with schizophrenia: Moderated by brain cortical thicknessChen Lin, Mengzhuang Gou, Shujuan Pan, et al.
Psychiatric Genetics|September 14, 2023
A novel risk variant block across introns 36-45 of CACNA1C for schizophrenia: a cohort-wise replication and cerebral region-wide validation studyXiaoyun Guo, Shibin Wang, Xiandong Lin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 26, 2023
Role of the immune-kynurenine pathway in treatment-resistant schizophreniaWenjin Chen, Yichang Tian, Mengzhuang Gou, et al.
Psychiatry Research. Neuroimaging|February 17, 2020
Hippocampus and cognitive domain deficits in treatment-resistant schizophrenia: A comparison with matched treatment-responsive patients and healthy controls<sup>✰,✰✰,★,★★</sup>Junchao Huang, Yu Zhu, Fengmei Fan, et al.
Psychopharmacology|January 6, 2022
Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority studyLe Xiao, Qian Zhao, An-Ning Li, et al.
Molecular Neurobiology|November 6, 2023
Correlation of Immune-Inflammatory Response System (IRS)/Compensatory Immune-Regulatory Reflex System (CIRS) with White Matter Integrity in First-Episode Patients with SchizophreniaMengzhuang Gou, Wei Li, Jinghui Tong, et al.
Brain, Behavior, and Immunity|June 27, 2025
Serum kynurenine metabolites and cytokine levels: diagnostic and predictive implications in acute manic episodes of bipolar disorderWei Li, Zhaofan Liu, Jue Wang, et al.
Schizophrenia Bulletin|June 12, 2023
Pleiotropic Association of CACNA1C Variants With Neuropsychiatric DisordersZuxing Wang, Xiandong Lin, Xinqun Luo, et al.
Schizophrenia Bulletin|October 15, 2024
N-Methyl-d-Aspartate Receptor Antibody and Sensory Gating Deficits in Non-smoking, Minimal Antipsychotic Medication Exposure, and First-Episode Patients With SchizophreniaJinghui Tong, Kebing Yang, Wei Li, et al.
Pageof 22